Kostelidou K.,COST Office |
Babiloni F.,University of Rome La Sapienza
Nonlinear Biomedical Physics | Year: 2010
A COST Action is a consortium of -mainly- European scientists (but open to international cooperation) working on a common research area, with the same subject; COST provides funding to the Actions for networking and dissemination activities, thus the participating scientists must have secured research funding from other national or European sources. COST funding is in the scale of approximately 100 kEuros per year and in this vein, it is often criticized both in that it does not fund research and the core science and in that its funding is 'limited'. However, COST with its instruments is an integral pillar of the European Research Area, and it is through its mission that a variety of aspects of the research environment, fundamental to the success of the research, are catered for; these include scientific networking, collaboration/exchange/training and dissemination activities. Through fast procedures, proposals are evaluated and approved for funding in less than one year from submission date and Actions become operational immediately, managed on flexible management. In this way, COST contributes to reducing the fragmentation in European research investments, while opening the European Research Area to cooperation worldwide. COST Actions have an excellent record of building the critical mass for follow up activities in the EU FP or other similarly competitive programmes.© 2010 Kostelidou and Babiloni; licensee BioMed Central Ltd.
Magez S.,Vrije Universiteit Brussel |
Caljon G.,Vrije Universiteit Brussel |
Caljon G.,Institute of Tropical Medicine |
Tran T.,Vrije Universiteit Brussel |
And 2 more authors.
Parasitology | Year: 2010
Anti-trypanosomiasis vaccination still remains the best theoretical option in the fight against a disease that is continuously hovering between its wildlife reservoir and its reservoir in man and livestock. While antigentic variation of the parasite surface coat has been considered the major obstacle in the development of a functional vaccine, recent research into the biology of B cells has indicated that the problems might go further than that. This paper reviews past and current attempts to design both anti-trypanosome vaccines, as well as vaccines directed towards the inhibition of infection-associated pathology. © 2010 Cambridge University Press.
Arnaldi S.,Istituto Jacques Maritain |
Boscolo F.,COST Office |
Stamm J.,COST Office
European Review | Year: 2010
COST (European Cooperation in Science and Technology) is one of the longest-running European instruments supporting cooperation among scientists and researchers across Europe. COST is an intergovernmental framework composed of 35 countries, allowing the coordination of research that is otherwise funded on a European level, through the provision of platforms for European scientists to cooperate on a particular project and exchange expertise. As a precursor of advanced multidisciplinary research, COST contributes to reducing the fragmentation in European research investments and to opening the European Research Area to cooperation worldwide. It anticipates and complements the activities of the EU Framework Programmes, constituting a bridge towards the scientific communities of emerging countries. It also increases the mobility of researchers across Europe, fostering the establishment of scientific excellence (see www.cost.esf.org). COST Foresight 2030 was an initiative designed to explore a broadly-shared vision for a future world beyond 2030, permeated and shaped by the digital revolution. It consisted of a set of events presenting long-term perspectives in the selected fields - Information and Communication Technologies/Computer and Communication Sciences and Technologies (ICT/CCST), Energy, Food Security, Natural Resources Management, Life Enhancement and Society - which play fundamental roles in human life and which are envisaged to be highly influenced by ICT/CCST-enabling technologies. The workshop Living the Digital Revolution: The European Society in 2030, the concluding one of the six workshops of the initiative, gathered 20 distinguished scholars and experts from Europe and beyond (AU, NZ, US) for an exploratory brainstorming session. Representing various fields in the social sciences and humanities, such as sociology, education and learning, future studies, law and ethics, economics and business, demography and ICT, the experts focused on the possible trajectories of European societies with regard to the accelerating advancements in ICT/CCST leading up to 2030. Copyright © 2010 Academia Europaea.